OAM
TXG icon

Oxford Asset Management’s 10x Genomics TXG Stock Holding History

Oxford Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,352
Closed -$308K – 745
2025
Q3 		$308K Buy
+26,352
New +$344K 0.1% 345
2020
Q1 		– Sell
-11,953
Closed -$911K – 1234
2019
Q4 		$911K Sell
11,953
-80,647
-87% -$4.85M 0.03% 918
2019
Q3 		$4.67M Buy
+92,600
New +$5.12M 0.11% 209

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's TXG Position: Q4 2025 in Review

Oxford Asset Management sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 26,352 shares — an estimated $308K sold.

Oxford Asset Management first reported a position in TXG in Q3 2019 and held it in 3 quarters. The position peaked at $4.67M in Q3 2019. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Oxford Asset Management reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 26,352 10x Genomics shares in Q4 2025, an estimated $308K.
  • Oxford Asset Management first reported a position in 10x Genomics in Q3 2019 and held it in 3 quarters.
  • Oxford Asset Management's 10x Genomics position peaked at $4.67M in Q3 2019.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.